Market closed

Passage Bio/$PASG

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Passage Bio

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

Ticker

$PASG
Trading on

Industry

Biotechnology

Employees

60

ISIN

US7027121000

Passage Bio Metrics

BasicAdvanced
$22M
-
-$1.07
1.55
-
$22M
1.55
$0.55
$0.30
199K
4.07
3.964
35.566
41.586
-32.20%
-75.07%
0.35
0.35
-0.436
-42.49%
-32.43%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PASG

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Passage Bio stock?

What is the P/E ratio for Passage Bio stock?

Does Passage Bio stock pay dividends?

When is the next Passage Bio dividend payment date?

What is the beta indicator for Passage Bio?